Victoria Gratz
Luebeck, SH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Sequential Treatment With Targeted and Immune Checkpoint Therapy in Patients With BRAF Positive Metastatic Melanoma: The Importance of Timing?
Journal: Frontiers in medicine
Published: July 23, 2019
Immune checkpoint inhibitors and tuberculosis: an old disease in a new context.
Journal: The Lancet. Oncology
Published: July 17, 2019
Checkpoint Inhibition May Trigger the Rare Variant of Anti-LAD-1 IgG-Positive, Anti-BP180 NC16A IgG-Negative Bullous Pemphigoid.
Journal: Frontiers in immunology
Published: March 18, 2019
Intralesional interleukin-2: A novel option to maximize response to systemic immune checkpoint therapy in loco-regional metastatic melanoma.
Journal: Dermatologic therapy
Published: March 07, 2019
Immune Cell Infiltration of the Primary Tumor, Not PD-L1 Status, Is Associated With Improved Response to Checkpoint Inhibition in Metastatic Melanoma.
Journal: Frontiers in medicine
Published: December 07, 2018
Does the gastrointestinal microbiome contribute to the 'obesity paradox' in melanoma survival?
Journal: The British journal of dermatology
Published: April 18, 2018
Meningeal melanomatosis following discontinuation of dabrafenib: implications for the maintenance of long-term complete remission.
Journal: Melanoma research
Published: July 21, 2017
Response of BRAF(L597Q)-mutant melanoma to trametinib : Targeted melanoma therapy beyond BRAF(V600) mutations
Journal: Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
Published: May 06, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026